Literature DB >> 2455745

Density heterogeneity of human lung mast cells.

E S Schulman1, T J Post, R J Vigderman.   

Abstract

Suspensions of enzymatically dispersed human lung parenchymal mast cells were fractionated according to density by flotation through discontinuous Percoll gradients and examined for their responsiveness to release stimulants and pharmacologic agonists. Mast cells localized to all six density fractions (I-VI) examined: densities varied from specific gravities of 1.053 gm/ml to 1.123 gm/ml. Most (67%) lung mast cells localized to fractions III and IV, corresponding to specific gravities of 1.077 to 1.088 gm/ml, respectively. Histamine content increased with density from 2.7 +/- 0.3 pg per cell in fraction 1 to 4.8 +/- 0.7 pg per cell in fraction VI (mean +/- SEM; n = 19). Fraction III was least responsive to high concentrations of anti-IgE than to any other fractions and, along with fraction IV, the most responsive to ionophore A23187. All fractions released the arachidonate mediators prostaglandin D2 and leukotriene C4 in response to anti-IgE. In four of eight lungs tested, formyl methionine peptide (10(-6) to 10(-4) mol/L) weakly elicited histamine release (3% to 6%) in fractions I and II cells. Compound 48/80 (0.1 to 10 micrograms/ml; n = 3) failed to induce histamine release in any fractions. The cyclic adenosine monophosphate-active drugs, isoproterenol (10(-4) mol/L), dibutyryl cyclic adenosine monophosphate (3 mmol/L), and isobutylmethylxanthine (3 X 10(-4) mol/L) inhibited anti-IgE-induced histamine release from all fractions equivalently. Dimaprit (3 X 10(-5) mol/L) and cromolyn sodium (10(-5) -3 x 10(-3) mol/L) failed to significantly inhibit any fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455745     DOI: 10.1016/0091-6749(88)90055-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Effect of propolis on mast cells in wound healing.

Authors:  Poliana Ribeiro Barroso; Ricardo Lopes-Rocha; Everton Miguel Ferreira Pereira; Sandra Aparecida Marinho; João Luiz de Miranda; Nádia Lages Lima; Flaviana Dornela Verli
Journal:  Inflammopharmacology       Date:  2011-12-17       Impact factor: 4.473

2.  Characterization of Mast Cells from Healthy and Varicose Human Saphenous Vein.

Authors:  Katrine T Callesen; Sofia Mogren; Frida Berlin; Cecilia Andersson; Susanne Schmidt; Lotte Klitfod; Vanesa Esteban; Lars K Poulsen; Bettina M Jensen
Journal:  Biomedicines       Date:  2022-05-03

3.  Mast cell concentration in the wound healing process of incisions made by different instruments.

Authors:  Luciane H Azevedo; Suzana C O M de Sousa; Luciana Correa; Carlos de Paula Eduardo; Maria Lúcia Zaidan Dagli; Georgios Romanos; Dante A Migliari
Journal:  Lasers Med Sci       Date:  2008-10-21       Impact factor: 3.161

4.  Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages.

Authors:  Barbara Balestrieri; Francescopaolo Granata; Stefania Loffredo; Angelica Petraroli; Giulia Scalia; Paolo Morabito; Chiara Cardamone; Gilda Varricchi; Massimo Triggiani
Journal:  Biomedicines       Date:  2021-05-04

5.  An Optimized Protocol for the Isolation and Functional Analysis of Human Lung Mast Cells.

Authors:  Avinash Ravindran; Elin Rönnberg; Joakim S Dahlin; Luca Mazzurana; Jesper Säfholm; Ann-Charlotte Orre; Mamdoh Al-Ameri; Peter Peachell; Mikael Adner; Sven-Erik Dahlén; Jenny Mjösberg; Gunnar Nilsson
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.